Delhi HC bars Zydus from launching Nivolumab biosimilar till 2026

In a courtroom defeat for Zydus Lifesciences, the Delhi High Court has stayed the company from marketing its proposed biosimilar of the cancer drug Nivolumab

Torrent Pharma Launches a New Adult Nutrition Powder, Shelcal Total

In a move to gain traction in the consumer healthcare market, Torrent Pharmaceuticals has launched Shelcal Total, a complete nutrition supplement powder for adults. “India is facing a growing nutrition gap driven by lifestyle changes...

Cipla invests in iCaltech to boost respiratory health portfolio

Cipla Limited said that it entered into definitive agreements to invest in iCaltech Innovations Private Limited by Optionally Convertible Preference Shares.

Godavari Biorefineries Gets China Patent for Promising Cancer Drug

Through its clinical-stage biotech subsidiary Sathgen Therapeutics, Godavari Biorefineries Limited has received a patent for its innovative anti-cancer chemical, HYDROXY-1,4-NAPHTHALENEDIONE, from China's patent and trademark authority, the China

Centre Approves 48 Pharma Projects to Boost Local Manufacturing

In a massive push to turn India pharma-independent, the central government has sanctioned 48 new projects under the PLI scheme to increase domestic production of essential drug ingredients called APIs and KSMs...

ICMR Invites Industry to License Its Indigenous Malaria Vaccine

In a significant boost to the biopharma sector, the Indian Council of Medical Research (ICMR) has issued an Expressions of Interest (EoI) to license its indigenous malaria vaccine, AdFalciVax. The vaccine targets Plasmodium falciparum...

DBT Launches AI-Backed Image Biobanks to Boost Diagnostics

The Department of Biotechnology (DBT) has released a flagship program for establishing a countrywide network of artificial intelligence

India Saves Rs 1,362 Cr in Pharma Imports via Local Drug Push

India saved ?1,362 crore in pharma raw material imports due to strategic investment under the PLI Scheme for Bulk Drugs, the government told Parliament on Tuesday.

ADIA Invests USD 200 Million in India's Meril to Boost MedTech Growth

In an important development demonstrating confidence in the global healthcare sector of India, Abu Dhabi Investment Authority (ADIA) has completed a definitive investment agreement for USD 200 million in Meril, a high-quality medical device company..

Ayurveda Offers Natural Solution for Irregular Periods

Hailing from one of Eastern India's oldest surviving Ayurvedic families

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.